Dr-Who - Latest News on Dr-Who | Read Breaking News on Zee News

India drugmaker stocks exception in Asian rout

Last Updated: Thursday, September 3, 2015, 19:37

In Mumbai trading so far this year, Lupin Ltd has climbed 32 percent, Dr. Reddy`s 31 percent, Glenmark Pharmaceuticals 42 percent and Wockhardt 29 percent.

India drugmaker stocks exception in Asian rout

Last Updated: Thursday, September 3, 2015, 08:14

Continued strength in the dollar when the Federal Reserve raises interest rates will also boost their income. More than 40 percent of over-the-counter and generic prescription drugs sold in the United States come from India.

Essel, CII ink pact for technical consortium for Smart Cities

Last Updated: Thursday, August 13, 2015, 19:19

The India Technical Consortium would be set up under the CII National Mission on Smart Cities, the company said in a statement.

Dr Reddy's to market three Amgen drugs in India

Last Updated: Thursday, August 6, 2015, 12:57

Dr Reddy's Laboratories on Thursday said it has inked a pact with US-based biotechnology firm Amgen to market its three drugs used to treat heart diseases and cancer in India.

Dr Reddy's shares gain over 5% on Q1 net jump

Last Updated: Thursday, July 30, 2015, 17:39

At the NSE, shares of the company rose by 5.4 percent to close at Rs 3,913.10.

DRL's net up 14% at Rs 626 crore; Russia a drag

Last Updated: Thursday, July 30, 2015, 14:45

The company had posted a net profit of Rs 550.39 crore for the corresponding quarter of the previous fiscal, Dr Reddy's Laboratories said in a BSE filing.

Inflation expected to remain within RBI's indicative trajectory: FICCI

Last Updated: Tuesday, July 14, 2015, 16:54

Dr. Suri said the wholesale price index based inflation rate remained unchanged at (-) 2.4 percent in June 2015.

Dr Reddy's Laboratories working on 18 new drug applications

Last Updated: Sunday, June 21, 2015, 21:32

Drugmaker Dr Reddy's Laboratories Limited is working on 18 new drug applications, including the three NDAs it has already filed with the US Food and Drug Administration, and expects 2 more drugs to go for approvals before 2018.

Dr Reddy's launches hair growth supplement

Last Updated: Friday, June 19, 2015, 21:08

The supplement provides key nutrients needed for maintaining healthy hair and according to the company, has a unique formula including grape seed extract containing potent antioxidants.

Dr Reddy's Lab completes acquisition of UCB's select brands

Last Updated: Friday, June 19, 2015, 13:23

Dr Reddy's has said the acquired UCB portfolio would accelerate its presence in the high growth areas of dermatology, respiratory and pediatrics, with market leading brands such as Atarax, Nootropil, Zyrtec, Xyzal and Xyzal M.

AstraZeneca, Dr Reddy's ink diabetes drug distribution pact

Last Updated: Friday, May 29, 2015, 19:32

AstraZeneca Pharma India and Dr Reddy's Laboratories on Friday entered into a distribution agreement for two drugs -- Riax and Riax-M -- used for treatment of diabetes in India.

Dr Reddy's scrip gains nearly 4% on launching drug

Last Updated: Monday, May 18, 2015, 20:43

Shares of Dr Reddy's Laboratories Monday rose by nearly 4 percent after the company launched Somazina, a drug used for treating those who have suffered stroke, in India.